Alembic Pharmaceuticals zooms on getting EIR from USFDA for Karakhadi facility

08 Jul 2016 Evaluate

Alembic Pharmaceuticals is currently trading at Rs 601.05, up by 20.95 points or 3.61% from its previous closing of Rs. 580.10 on the BSE.

The scrip opened at Rs. 582.30 and has touched a high and low of Rs 624.00 and Rs. 576.30 respectively. So far 85455 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 791.70 on 15-Jul-2015 and a 52 week low of Rs. 514.35 on 05-Feb-2016.

Last one week high and low of the scrip stood at Rs 624.00 and Rs 573.05 respectively. The current market cap of the company is Rs 11328.86 crore.

The promoters holding in the company stood at 74.13%, while Institutions and Non-Institutions held 13.54% and 12.33% respectively.

Alembic Pharmaceuticals has received Establishment Inspection Report (EIR) from US Food & Drug Administration (USFDA). The regulator had carried out the inspection at the Company's Karakhadi API Plant III in April, 2015.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907. The company manufactures and markets generic pharmaceuticals products all over the world.

Alembic Pharma Share Price

1031.10 -23.90 (-2.27%)
23-Dec-2024 09:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.95
Dr. Reddys Lab 1340.40
Cipla 1465.00
Lupin 2133.45
Zydus Lifesciences 965.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.